Related Experiment Videos
The nuclear pregnane X receptor regulates xenobiotic detoxification
1Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390-8594, USA. steven.kliewer@utsouthwestern.edu
The Journal of Nutrition
|July 4, 2003
Summary
The pregnane X receptor (PXR) protects the body from toxins. PXR activation by drugs and herbs can cause harmful drug interactions, which can be predicted by PXR activation assays.
Area of Science:
- Biochemistry
- Pharmacology
- Toxicology
Background:
- The pregnane X receptor (PXR) is a nuclear receptor that acts as a defense mechanism against toxic substances (xenobiotics).
- PXR is activated by a wide range of lipophilic compounds, including pharmaceuticals, herbal remedies, pesticides, and environmental contaminants.
- Its large, flexible ligand-binding pocket allows it to bind diverse molecules.
Purpose of the Study:
- To highlight the role of PXR in xenobiotic metabolism and detoxification.
- To explain the molecular basis of drug-drug interactions mediated by PXR activation.
- To emphasize the utility of PXR activation assays in predicting and preventing adverse drug events.
Main Methods:
- The study reviews the known functions and characteristics of PXR.
- It discusses the interaction of PXR with various xenobiotics, including prescription drugs and herbal supplements like St. John's wort.
- The mechanism of PXR-mediated gene regulation and its role in drug metabolism are examined.
Main Results:
- PXR forms a heterodimer with the 9-cis retinoic acid receptor (RXR) to regulate genes involved in detoxification and excretion.
- Activation of PXR by common drugs and herbs is a significant cause of drug-drug interactions.
- The promiscuous binding of PXR contributes to its broad substrate specificity.
Conclusions:
- PXR is a critical player in the body's response to xenobiotics.
- Understanding PXR activation is essential for managing drug-drug interactions.
- PXR activation assays offer a valuable tool for predicting and mitigating potential drug interactions.